Autoimmune Disease Diagnostics Market – Growth, Trends, and Forecasts (2017–2025)

Autoimmune Disease Diagnostics Market Overview:

The immune system of human body recognize some invaders such as bacteria, viruses, and external chemicals and attacks those to protect the body. However, sometimes the immune system attacks the healthy cells of body by considering them as foreign cells. Such a condition is called autoimmune disease. The autoimmune disease causes abnormal organ growth and changes in organ function. The genes of an individual with environmental exposure might be the major reason for autoimmune disease development. Some of the common autoimmune diseases among over 80 types of autoimmune diseases are type 1 diabetes, systemic lupus erythematosus, inflammatory bowel disease, rheumatoid arthritis. The curing therapy for autoimmune diseases is not yet available only relieving treatments are available for this diseases. Diagnosis of the autoimmune diseases can be done by the tests which involves antinuclear antibody test, antibody test, complete blood counts and some others.

Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/419

The growing incidences of autoimmune diseases and government initiatives to boost the autoimmune disease diagnostics market

According to American Autoimmune Related Disease Association (AARDA), in 2016, around 50 million people suffered from autoimmune diseases in the U.S. with 75% being women. Increasing incidence of autoimmune diseases, rising public awareness and government initiatives taken to spend the budget on diagnosis and care services for autoimmune diseases, are some of the factors which are driving the autoimmune disease diagnostics market. Many of the organizations and governments are funding the research and development program for autoimmune diseases, this will help to launch the new products in the market and definitely help in the growth of autoimmune disease diagnostics industry. For instance, the discovery of novel biomarkers, which has proven to be significant to improve the diagnosis of autoimmune diseases is also one of the major factor driving the autoimmune diseases diagnostic market.

Despite of all the driving factors for the autoimmune disease diagnostics market there are some restraints which slowing down the market such as, high rate of false results, slow turnaround time for test results and lack of experience and education of laboratory personnel in the diagnostics of certain autoimmune diseases.

Aging population and technological advancements in diagnosis of rheumatoid arthritis will be the cause of growth for rheumatoid arthritis segment

The global autoimmune disease diagnostic market are segmented on the basis of disease type, test type, end user and geography

On the basis of disease type, the autoimmune disease diagnostic market is segmented into:

  • Systemic Autoimmune Disease diagnostics

  • Rheumatoid Arthritis

  • Ankylosing Spondylitis

  • Systemic Lupus Erythematosus

  • Some Others

  • Localized autoimmune disease diagnostics

  • Multiple Sclerosis

  • Type 1 diabetes

  • Hashimoto’s thyroiditis

  • Idiopathic Thrombocytopenic purpura

The high patient awareness level and large procedure volumes are the reasons that localized autoimmune disease diagnostics is dominating the overall market. Though the initiatives taken by government for patients suffering from rheumatoid arthritis and systemic lupus erythematosus will aid in the growth of systemic autoimmune disease diagnostics segment.

On the basis of test type, the global autoimmune disease diagnostic market is segmented into:

  • Antinuclear Antibody Tests

  • Autoantibody Tests

  • Complete Blood Count

  • C-reactive Protein

  • Others

On the basis of end user, the global autoimmune disease diagnostics market is segmented into

  • Hospitals

  • Diagnostics Centers

  • Research Laboratories

The technological advancements in the North America region driving the autoimmune disease diagnostics market

The regional segmentation of autoimmune disease diagnostics market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Africa and rest of the world. North America is of the largest revenue contributor in the global autoimmune disease diagnostics industry. This is mainly attributed to rising incidence of some of the common autoimmune diseases like rheumatoid arthritis and type1 diabetes. The increase in funding by government and private sector, increasing regulatory scenario monitored by World Health Organization (WHO), and technological advancements are some of the factors which are driving growth of the autoimmune disease diagnostics market in the North America region. Asia Pacific is projected to be a fast emerging region in the global autoimmune disease diagnostic market.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/419

The introduction of novel biomarkers in the market will aid in the growth of autoimmune disease diagnostic market

The key players operating the autoimmune disease diagnostics market are Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Euroimmun, Inova Diagnostics, Roche Diagnostics, Siemens Healthcare, A. Menarini Diagnostics, Adaptive Biotechnologies, AESKU Diagnostics, and many others. The government agencies of various countries are increasing their healthcare spending to provide better health care services, and the introduction of novel biomarkers in the research area, owing for ample opportunity for the key players, which in-turn will boost the autoimmune diseases diagnostic market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Anesthesia and Respiratory Devices Market – Growth, Trends, and Forecasts (2016–2024)

Anesthesia and Respiratory Devices Market Overview:

Anesthesia is a state in which a person has temporary induced loss of sensation or awareness provided by the anesthesia devices. Anesthesia device provide accurate and continuous supply of medical gases mixed with an accurate concentration of anesthetic vapor. Anesthesia provides painless performance of medical procedures that could serve intolerable pain to an un-anesthetized patient. There are three types of anesthesia general anesthesia, sedation anesthesia and regional or local anesthesia. While respiratory devices are used to provide medication or to comfort patient who have difficulty in breathing and cannot acquire sufficient level of oxygen to maintain life. Patient with respiratory disease use various respiratory devices that help to remove the mucus from the airway and improve the function of pulmonary. Respiratory devices lead the market as compared with anesthesia device as anesthesia devices has limited end user.

Furthermore, increase in aging population who suffer from asthma, pulmonary disease and chronic obstructive pulmonary disease is expected to favor the anesthesia and respiratory device market. According to world ageing population reports in the U.S. between 2015 and 2030, the number of people in the world aged 60 years or over is projected to grow by 56 per cent, from 901 million to 1.4 billion, and by 2050, the global population of older persons is projected to more than double its size in 2015, reaching nearly 2.1 billion. Increase in number of surgeries worldwide also fuels the anesthesia and respiratory device market. Moreover, continuous technical advancement in anesthesia and respiratory devices is another driving force for the growth of market.

Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/532

Anesthesia and respiratory devices market taxonomy

By Product Type

  • Anesthesia Devices

  • Anesthesia Machines

  • Anesthesia Disposables

  • Respiratory Devices

  • Respiratory Equipment

  • Respiratory Disposables

  • Respiratory Measurement Devices

By End User

  • Anesthesia Devices

  • Hospital

  • Ambulatory Surgical Centers

  • Respiratory Devices

  • Hospital

  • Ambulatory Surgical Centers

  • Homecare Settings

Rise in number of surgeries fuel the anesthesia and respiratory device market

Anesthesia devices are used commonly in all types of surgeries as they are designed to provide an accurate and continuous supply of mixed medical gases with anesthetic vapors which is delivered to patient at a safe pressure and flow. According to Centers for Disease Control and Prevention in year 2010, 16 million operative procedures were performed in the U.S. whereas rise in number of patient who suffer from respiratory disease favors growth of the market. According to the Center for Disease Control and Prevention in year 2016 estimated that 24 million people, including more than 6 million children have asthma in the U.S.

Furthermore, demand for anesthesia devices are rapidly increased due to growth in safety awareness and technology enhancement. Moreover, Obstructive sleep apnea also favor the growth of market as this type of apnea occurs to throat muscles when they relax, which leads to blockage of airway during sleep and so to the treat OBA disorder respiratory devices are used.

Regional growth engines of the anesthesia and respiratory device market

In terms of geography anesthesia and respiratory device market is segmented into North America, Europe, Asia Pacific, Middle East, Latin America and Africa. Due to presence of high income and health awareness in North America favors the growth of market. Additionally, the leading cause of death in North America is chronic obstructive pulmonary disease (COPD) as it is the third leading cause of death in North America. The above statistics supports the growth of anesthesia and respiratory device market.

Furthermore, due to economic development, health reform by government and increase in investment in research and development in Asia Pacific region is expected to show growth in the market.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/532

The key players dominating the global anesthesia and respiratory device market

Providers in the market offer a broad range of anesthesia and respiratory device and introduction of low priced multi-featured devices in market is increasing the product competition in market within the manufactures. The key player operating the market of anesthesia and respiratory device includes Fisher & Paykel Healthcare, Invacare, GE Healthcare, Teleflex, Philips Healthcare, Drägerwerk AG, Medtronic, Smiths Medical, OSI systems and Getinge AB.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Biomedical Refrigerators Market – Global Industry Insights and Forecast till 2025

Biomedical Refrigerators Market Overview:

Biomedical refrigerators are medical equipment that are used for storing various biological samples such as biological reagents, medicines, vaccines, blood, blood derivatives, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and flammable chemicals. Samples with biological origin require accurate conditions for effective storage. As compared to domestic refrigerators, biomedical refrigerators provide most favorable conditions for efficient storage of samples with biological origin. These refrigerators are widely used in blood banks, research laboratories, hospitals, educational institutes, and diagnostic centers. This refrigerators need to be totally hygienic and completely reliable and need to maintain a consistent temperature in order to reduce the risk of bacterial contamination and explosions of unstable materials. To attain a high degree of accuracy the refrigerator needs air to circulate and a fan to maintain constant temperature at all times. The fan turns off when the door is open to prevent cold air from blowing out of the unit. Biomedical refrigerators feature distinct compartments as to prevent cross contamination and can hold specific medical supplies, such as blood or vaccines.

Escalating demand for cellular therapies, blood transfusions, organ transplant, and biopharmaceuticals is stimulating growth of the biomedical refrigerators market. In addition, increasing biomedical R&D activities all over the world are boosting demand for biomedical refrigerators. However, presence of large number of local players and increasing use of renewed equipment are some of the factors hampering the growth of the global biomedical refrigerators market. With rapid technological advancement and with expansion of various technological and infrastructural upgrade of clinics, hospitals and research laboratories, the global biomedical refrigerators market is expected to have a substantial growth in the forecast period.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/381

Biomedical Refrigerators Market

On the basis of product type, the global market are classified into:

    • Blood Bank Refrigerators

    • Laboratory Refrigerators

On the basis of end user, the global market are classified into:

    • Hospitals

    • Pharmacies

    • Diagnostic Centers

    • Research Laboratories

    • Blood Banks

Factors like the increasing importance on energy efficient refrigerators driving the prospects for market growth until the end of the forecast period. The environmental challenge for biomedical refrigerator manufacturers has always been to reduce energy consumption. According to the current standards, refrigerants used have minimum global warming potential, an ozone depleting potential of zero, and be nontoxic as well as inflammable. It is highly challenging to meet all these desires while maintaining a stable temperature control. Therefore, manufacturers are focusing on developing technologies to maximize efficiency and temperature consistency while minimizing heat and energy consumption. Improvement of healthcare infrastructure due to the increasing support from government and industry participants to provide technical and financial assistance in procurement of biomedical refrigerators is a positive trend witnessed in the market.

North America held the maximum share, mainly attributed to presence of stringent procedures in the U.S., high quality standards, and high expenses on hospital and healthcare infrastructure is a key factor for the regions dominance. The U.S. spends major share of its GDP toward healthcare, and it is a main concern to improve patient care, reduce the wastage of pharmaceutical and biological components. Growing prevalence of chronic diseases coupled with increasing geriatric population that is significantly driving the number of blood transfusion procedures, consumption of various pharmaceutical products. This factor is boosting demand for use of biomedical refrigerators across all the end use segments. Developing countries such as India, China, Indonesia and others is a key factor boosting the expenditure on healthcare infrastructure and medical services. This region is emerging as key medical tourism destination, and the government and private sector are investing significant resources to the reach the service quality standards adopted in the western regions.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/381

Key players operating in the global biomedical refrigerators market are Thermo Fisher Scientific, Aegis Scientific, Inc., Panasonic Healthcare Co. Ltd., Eppendorf AG, Terumo Corporation, Haier Biomedical, Philipp Kirsch GmbH, Leibherr Group, Inc., and Helmer Scientific.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Venipuncture Needle and Syringes Market – Growth, Trends, and Forecasts (2016–2024)

Venipuncture Needle and Syringes Market Overview :

Venipuncture is a perforation on a vein as part of a medical practice, basically to draw a blood sample and or to inject a drug into the body. This is done by intravenous cannulation. The venipuncture blood collection is carried out with the help of needle and syringes. Venipuncture is the oldest invasive procedures, which is carried out for five basic reasons and they are to collect blood for investigative purposes, identify the levels of blood components, and administer medications, nutrition, or chemotherapy, to eliminate blood due high presence of iron or erythrocytes and to collect blood which might be useful later in transfusion purpose. This can be possibly done with the use of venipuncture needle and with the immense increase in the blood test and blood collection, there is a proportional increase in the venipuncture needle and syringe market.

Excessive blood withdrawn may lead to hematocrit in older patients

According to Van Roekel, CEO Nuno Valentine, said that there are about half of doctors do not have sufficient funds to support a phlebotomist, and some are located in an area where there are no staff sufficient members. Mr. Kapadia, a chief medical officer of Iggbo, explains that bloodwork justifies about 75% if the medical decision. According to Van Roekel, there are 1 billion blood sample are drawn in the United States every year and out of which 50,000 blood draws in Houston daily. There are many literature stating that the excessive blood drawing from an individual causes a big setback in elderly person. A cohort study report states that public hospitals and university hospitals drew more blood for each test than that is followed in children’s hospitals. For the basic metabolic tests, the volume of blood drawn by an university or public hospital laboratory was 2.5 to 10 times more required by any children’s hospital, though there are similar tests and instruments used. Excess withdrawn of blood may lead to change in hematocrit which may lead to a down fall in elderly patient health. This is a major concern in the increasing number of older persons.

Get an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/176

Median Cubital Vein to dominate the venipuncture needle and syringes market globally

The global venipuncture needle and syringes market is segmented on the basis of vein type, end user, and geography. On the basis of vein type, the market is divided into Cephalic Vein, Median Cubital Vein, and Basilic Vein. On the basis of end user, the market is divided into Hospitals, Diagnostic Labs and Physicians’ Offices.

Advanced syringe and methods to collect the blood sample to overtake the conventional way of blood collection emphasizing the growth in venipuncture needle and syringes market

Regional segmentation of the market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America accounts for the largest share in venipuncture needle and syringes market, mainly due to presence of key players and their application of advanced medical technologies to develop in countries such as the North America and Africa. Increase in the diagnostic test for any disease needs blood sample which therefore is useful to obtain results. Therefore, the use of venipuncture needles and syringes are proportionally increasing. In Africa according to World Health Organization, it is almost 85% of all the chronic disease needs blood test.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/176

Key players in the global venipuncture needle and syringes market are developing new devices, which collect the required amount of blood

Key players operating the venipuncture needle and venipuncture syringes market include Smiths Medical, Becton, Dickinson and Company, and B. Braun Medical. Key players in the market globally are constantly working towards introducing innovative products which firstly identify veins and collect blood sample. With companies actively focused on research and development, a new product which is virtually painless way to draw blood. This company is expected to launch its product in mid 2017 as the company has responded to its pending queries from FDA.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Global Infusion Pumps Market, By Device Types, Application, Channel Type , End User- Trends, Size, and Forecast 2024

The Global Infusion Pumps Market was valued at US$ 2,985.5 million in 2015 and is projected to expand at a CAGR of 6.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Increasing number of applications of infusion pumps in the healthcare sector is projected to support growth of the infusion pumps market over the forecast period.

Infusion pump delivers controlled amount of fluid and medications into the bloodstream over a period of time. The drug infusion system includes two components, namely open loop and closed loop. According to a study by Healthcare Human Factors University Health Network, in 2009, around 13% of the hospitals in Ontario used smart pumps and around 6% were in the process of implementing the techniques. Thus, adoption rate of smart large volumetric infusion pumps in Ontario has been low. Infusion pumps have contributed to improvements in patient care at affordable costs. Apart from its wide application in hospitals and for clinical use, the systems are also used in the form of portable device to provide the drug or fluid on the move. Furthermore, the major application that has revolutionized the use of infusion pumps involves diabetes where it works as an insulin pump to provide with the controlled and preset amount of insulin in the patient’s body. According to the fact sheet by W.H.O, number of diabetic patients witness a steep increase from 108 million in 1980 to 422 million in 2014. This in turn is expected to favor the market growth for infusion pumps over the forecast period.

To know the latest trends and insights prevalent in the infusion pumps market, click the link below:

https://www.coherentmarketinsights.com/market-insight/infusion-pumps-market-127

The development of combination in medical device technology and advanced drugs are the precursor for adoption of control infusion therapies, which have increased the use of infusion pumps globally. Currently, there are various clinical applications of infusion pumps that involves life-sustaining along with life-saving treatments under other clinical segments such as anesthesia, intensive care, and oncology. Infusion pumps are used in various settings such as wards, home care environment and hospitals for pain management and other drug related treatments. Furthermore, rapid development of the healthcare infrastructure in emerging economies and upgrade of the same in developed regions creates a highly conducive environment for growth of the infusion pumps market in the near future.

Major players in the global infusion pumps market are laying emphasis on product development, upgrading existing devices, and geographical expansions through various strategic mergers and acquisitions. For instance, in 2015, InfuSystem Holdings, Inc. –an infusion pumps provider and related healthcare services in the U.S. and Canada –acquired Ciscura Holding Company, Inc. – a provider of ambulatory infusion pumps and healthcare services to medical facilities. Also, in 2016, ICU Medical Inc. – a developer and manufacturer of medical devices specific in the areas of vascular therapy, oncology and critical care applications – acquired Hospira Infusion Systems business from Pfizer Inc. for a total value of US$1 billion in cash and stock.

Get an exclusive discount on this report : https://www.coherentmarketinsights.com/insight/request-discount/127

Key takeaways of the market:

  • The global infusion pumps market is expected to expand at a CAGR of 6.0% during the forecast period (2016–2024). Rising prevalence of diabetes across the globe is expected to favor the infusion pumps market growth over the forecast period.

  • The analgesia application segment in the global infusion pumps market was estimated to be the largest in 2015 and is expected to retain its dominance in the market throughout the forecast period in terms of value. Increasing prevalence for chronic pain globally is expected to favor the growth for infusion pumps market in the near future. According to British journal of anesthesia, in 2013, around 20% of the European population was suffering from chronic pain.

  • In terms of product type, the insulin product type segment is expected to expand at a significant CAGR of 6.9% during the forecast period, owing to rise in population suffering from diabetes globally

  • The global infusion pumps market is characterized by strategic research and development and advancements in the technology of various medical devices including the continuous glucose monitoring device and infusion pumps.

  • Some of the major players in the global infusion pumps market include Medtronic Plc., ICU Medical Inc., Johnson & Johnson Private Ltd., Braun Melsungen AG., Smiths Medical, CareFusion Corporation, Baxter International Inc., Fresenius Kabi AG, MOOG Inc., Terumo Corporation, Nipro Corporation and Codman & Shurtleff, Inc., Infusystem

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Raj Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

3D Printed Medical Devices Market – Growth, Trends, and Forecasts (2016–2024)

Global 3D Printed Medical Devices Market

3D Printing: Ushering in the New Era of Customized Medical Devices

3D printed medical devices are three-dimensional objects, created by attaching successive layers of objects through a 3D digital file. Such devices are highly customized to suit the patient’s unique needs, which in turn helps provide better patient outcomes. Moreover, it can also be used to develop anatomical models for medical related education and for training purposes. This is a rapidly emerging technology facilitating production of different kinds of medical products such as implants, surgical instruments, and external prosthetics. The process of 3D printed medical device manufacturing involves multiple steps. These steps depend upon the type of printing and the complexity of the equipment.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/29

Technological advancements making 3D-printed devices more affordable

Factors driving growth of the 3D printed medical devices market include rising technological advancements through development of innovative 3D printed medical equipment and increasing healthcare spending worldwide. For instance, Stratasys Ltd. is focusing on development of extensive detailed prototypes or molds made of flexible and transparent materials for detailed study of chronic diseases. Moreover, aging population also contributes towards the demand for these devices. This is primarily due to the fact that this particular demographic group is more susceptible to osteoarthritis, gangrene, as a risk of diabetes and chronic heart disorders. Rising incidence of road and other accidents is also expected to influence market growth. However, stringent regulatory framework, high cost of 3D printed devices, and low reimbursement policies are some of the factors restraining market growth for 3D printed medical devices.

Prosthetics and implants the mainstay of 3D-printed medical devices

The global 3D printed medical devices market is segmented on the basis of product type, raw material, technology, end user, and geography. On the basis of product type, the market is segmented into implants, surgical instruments, prosthetics, tissue engineering devices, and others. Implants is sub-segmented into cranial implants, orthopedic implants, and dental implants; surgical instruments is sub-segmented into scalpels, retractors, and others; tissue engineering devices is sub-segmented into bone and cartilage scaffolds and ligament and tendon scaffolds.

On the basis of raw material, the market is divided into plastics, biomaterial inks, and metal and alloys. Plastics are further divided into thermoplastics and photopolymers. Biomaterial inks include polymers, ceramics and hydrogels.

On the basis of technology, the market is segmented into Fused Deposition Modeling (FDM), Digital Light Processing (DLP), Stereolithography (SLA), Selective Laser Melting (SLM), Electron Beam Melting (EBM), Multi Jet Fusion (MJF), and others.

On the basis of end user, the market is classified into hospitals, diagnostic centers, academic institutions, and others.

Burgeoning geriatric population in Europe a highly lucrative market

Regional segmentation by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America accounts for the largest market share, mainly due to presence of major players and early adoption of advanced medical technologies in countries such as U.S. and Canada. Europe is the second-largest market, owing to the large target population, especially comprising of elderly people, with high approval for use of 3D-printed medical devices. Growing disposable income and increasing awareness levels among the populace in Asia Pacific, along with a large population base is expected to position Asia Pacific as a high growth market in the near future.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/29

Stratasys Ltd. is one of the major companies for 3D printed medical devices market

Key players operating the 3D medical devices market include 3D Systems, Inc., Stratasys Ltd., EOS GmbH Electro Optical Systems, Arcam AB, FabRx Ltd., Bio3D Technologies, EnvisionTEC, Cyfuse Biomedical K.K., Concept Laser GmbH, 3T RPD, Ltd., and Prodways. Major companies in the market are constantly working towards introducing innovative products and lower production costs in order to enhance profitability. For instance, in November 2016, 3D Systems extended its anatomical modeling service aimed at including pliable MultiJet Printing (MJP) material for patient-specific 3D modelling and printing services.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Ulcerative Colitis Market – Growth, Trends, and Forecasts (2016–2024)

Ulcerative Colitis Market Overview:

Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained weight loss, loss of appetite, joint pain, eye disease, thickening of the intestinal wall, blood infection (sepsis), kidney stones and liver disease. The diagnosis of this disease can be carried out by physical examination using tests such as colonoscopy, endoscopy, biopsy, CT scan and blood test.

If ulcerative colitis persists for over 8 years or longer, it may lead to colon cancer. The people having mild symptoms of this disease can be cured by over the counter drugs such as Imodium therapy. However, transcription medicine such as steroid medicines and amino salicylates are widely used to treat the condition. In severe cases, the patient may need to undergo surgery to remove the colon, which also helps prevent colon cancer.

Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/238

Also, some genetically engineered drugs also used to treat ulcerative colitis. These drugs are made up of certain living organisms that help suppress the inflammation, by targeting the inflammatory proteins such as cytokines. Some genetically engineered drugs approved by the U.S. FDA for treatment of the condition are Adalimumab (Humira), Golimumab (Simponi), Infliximab (Remicade) and Vedolizumab (Entyvio).

These genetically engineered drugs may show some side effects such as fever, headache, hives, low blood pressure, breathing difficulties, back pain, and stomach pain. Also, these drugs may affect the immunity power of body to fight infection.

The exact cause for ulcerative colitis is unknown, though possible reasons are may be genetic factors, environmental changes, or weakened immune system. The ulcerative colitis can be prevented by simple healthy habits such as eating small meals throughout the day, staying well hydrated throughout the day, avoiding fatty foods, and limiting intake of high-fiber food.

According to data released by the Centers for Disease Control and Prevention (CDC), there are around 2.2 to 14.3 cases found per 100,000 population per year. Also, according to a study conducted in 2014 by Crohn’s & Colitis Foundation of America (CCFA), 907,000 people suffered from ulcerative colitis in the U.S. (data based on the research conducted in between 2011-2014 by CCFA)

Ulcerative colitis market taxonomy:

Global Market by Drug Type

  • Infliximab

  • Golimumab

  • Adalimumab

  • Vedolizumab

  • Mesalamine

  • Budesonide

  • Balsazide

Global Market by Dosage Form

  • Parenteral

  • Oral

Global Market by Geography

  • North America

  • Europe

  • APAC

  • Latin America

  • Middle East

  • Africa

High prevalence in developed regions and increasing incidence rate in emerging economies will play major role in driving growth of the ulcerative colitis market

According to the study of CCFA, industrialized countries have highest incidence rate for ulcerative colitis. This disease is most prevalent in urban areas than in rural areas, also it can affect to any age group of people but most cases diagnosed are of the age in between 15 to 35. According the stats of World Gastroenterology Organization (WGO), there is rising incidence rate in emerging economies such as India. Due to changing diet and lifestyle pattern, the emerging economies will show high growth rate in incidence rate of ulcerative colitis in the near future.

According to data collected from various sources and compiled by Coherent Market Insights, Europe have the highest annual rate of incidence worldwide, followed by North America and the lowest in Asia and Middle East.

However, North America holds the largest share in the global ulcerative colitis market due to continuous improvements in drugs, increased uptake of medicines, awareness about treatment and increasing clinical research. APAC region will show high growth in ulcerative colitis market during forecast years (2017-2024), due to raising awareness about the treatment, changing lifestyle will cause to increase prevalence and incidence rate, entry of new drugs in the market also some companies losing their patent of ulcerative drugs in coming years, like Humira (adalimumab) lost its patent in 2016 and Remicade will lose its patent in 2018. Also, some drugs companies have launched their biosimilar drugs in ulcerative colitis industry. For example, in 2016, India-based Torrent Pharmaceuticals launched a biosimilar drug under the brand name Adfra to compete Humira. Humira is a trade name for adalimumab medication owned by AbbVie Inc.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/238

Some major companies playing leading role in ulcerative colitis market are AbbVie Inc., Hospira, Celltrion Healthcare, Johnson and Johnson, F. Hoffmann-La Roche AG, Warner Chilcott, Janssen Pharmaceuticals Inc. and Takeda Pharmaceuticals Company Ltd.

Some leading drugs are used to reduce inflammation and swelling and to cure ulcerative colitis are include Sulfasalazine (Azulfidine), Mesalamine (Asacol and Lialda), Balsalazide (Colazal), and Olsalazine (Dipentum), Inflectra, Remsima, Adalimumab (Humira), Infliximab (Remicade).

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com